Contract Research Organisation (CRO)
Monoclonal antibodies are large molecules that comprise of hundreds of amino acids in addition to post-translational modifications. Elucidating the structure and functionality of these proteins is difficult but necessary for regulatory submissions. To develop therapeutic monoclonal antibodies, it is mandatory to conduct analytical studies, which must be tightly bound to production process control, since any change in any step of the process may modify the structure, hence the assertion that, the process is the product in biologic field.
Curaxys is specialized in the development of any monoclonal antibody, being able to carry out a complete process from the generation of the cell line that produces the target protein, to the physico-chemical characterization.
For those companies working to develop therapeutics monoclonal antibodies, Curaxys offers a complete package service, including analytical-bioanalytical assays and the production of the product to perform the preclinical characterization.
|Copyright 2012 Curaxys. All Rights Reserved|